Li Xie

Takeda Pharmaceutical Company Ltd., China (People's Republic)

Poster(s):

• P0914 - Clinical Effectiveness and Safety of Vedolizumab in Patients With Crohn’s Disease in China: Results From a Real World Study
  Sunday, October 27, 2024

  3:30 PM – 7:00 PM ET